Professor Andrew Hopkins is a highly esteemed scientist known for his significant contributions to modern drug discovery. He founded and serves as CEO of Exscientia, where he pioneered an automated and algorithmic approach to drug design. With a background in academia and 14 years at Pfizer, he has been at the forefront of using data mining and machine learning in pharmaceutical research, and his papers in Nature journals have been pivotal in shaping the new paradigm of drug discovery.